Heart Problem Pauses Hepatitis C Drug Study
Share
Follow Us
The Editors at Hepatitis Central
August 8, 2012
Trials on one of Bristol-Myers’ potential Hepatitis C drugs, BMS-986094, have been halted to investigate a possible case of related heart failure.
Bristol-Myers suspends hepatitis C treatment study, cites possible cardiac concern
Article by: TOM MURPHY , Associated Press
Updated: August 2, 2012 – 11:34 AM
Drugmaker Bristol-Myers Squibb Co. is suspending a midstage study of a potential hepatitis C treatment after at least one patient suffered heart failure.
The New York company hasn’t determined the cause or whether it is tied to the potential treatment, so it is examining all patients who took the drug.
Continue reading this entire article:
http://www.startribune.com/lifestyle/health/164724656.html?refer=y%22,,0,0,,,,
